Aims: Vitamin E (Vit-E) may preferentially improve cardiovascular risk in haptoglobin 2-2 (Hp2-2) genotype diabetes individuals. We studied the impact of Vit-E supplementation on vascular function in diabetes individuals stratified by haptoglobin genotype in Singapore.References:
Methods: In this 24-week, double blind, placebo-controlled RCT, we recruited 187 subjects (101 Hp2-2, 86 non-Hp2-2).
Intervention: alpha-tocopherol-400 IU.
Primary Outcome: Change in EndoPAT-derived reactive-hyperaemia index (RHI) and augmentation index (AIx); Secondary Outcomes: Pulse-Wave velocity (Sphygmocor-PWV), carotid intima media thickness (CIMT), inflammation (hsCRP), derivatives of reactive-oxygen metabolites (dROMs), biological antioxidant-potential (BAPs), HbA1c, LDL-C, HDL-C and oxidised LDL-C (ox-LDL).
Results: Overall, with Vit-E supplementation no significant change in RHI, PWV, CIMT, hsCRP, dROMS, BAPs, HDL-C and HbA1c was observed (p > 0.05); an increase in LDL-C with concomitant decrease in ox-LDL, and incidentally increase in eGFR was observed (p < 0.05). No interaction effect with haptoglobin genotype was seen for all outcomes (p > 0.05). Subgroup analysis: In the non-Hp-2-2 group, Vit-E supplementation led to a higher EndoPAT-derived AIx, accompanied by higher LDL and ox-LDL concentrations (p < 0.05); Hp2-2 group: Vit-E supplementation led to higher eGFR when compared to the non-Hp2-2 group (exploratory) (p < 0.05). We observed an interaction effect for baseline haptoglobin concentration (threshold > 119 mg/dl) with intervention in terms of increased EndoPAT-derived AIx in the Hp > 119 mg/dl group whereas no change in the group with Hp ≤ 119 mg/dl.
Conclusion: Vit-E supplementation did not show any preferential benefit or deleterious effect on vascular function in Hp2-2 diabetes subjects in Singapore. A possible deleterious effect of an increase in arterial stiffness in individuals with Hp > 119 mg/dl was observed. Future studies should consider personalisation based on baseline Hp concentrations in patients with T2DM rather than just Hp2-2 genotype to evaluate impact on the detailed lipid pathways, cardiac and renal physiology. The impact of ethnic differences needs to be explored in greater details.
Sarwar, N. et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Emerging Risk Factors Collaboration. Lancet 375, 2215–2222 (2010). (PMID: 10.1016/S0140-6736(10)60484-9)
Rask-Madsen, C. & King, G. L. Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes. Nat. Clin. Pr. Endocrinol. Metab. 31, 46–56 (2007). (PMID: 10.1038/ncpendmet0366)
Levy, A. P. et al. Haptoglobin: basic and clinical aspects. Antioxid. Redox Signal 12, 293–304 (2010). (PMID: 10.1089/ars.2009.2793)
Asleh, R. et al. Genetically determined heterogeneity in haemoglobin scavenging and susceptibility to diabetic cardiovascular disease. Circ. Res. 92, 1193–1200 (2003). (PMID: 10.1161/01.RES.0000076889.23082.F1)
Vardi, M., Blum, S. & Levy, A. P. Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus-natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature. Eur. J. Intern. Med 23, 623–632 (2012).
Blum, S. et al. Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2–2 genotype. Pharmacogenomics 11, 675–684 (2010). (PMID: 10.2217/pgs.10.17)
Dalan, R. & Goh, L. L. The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus. Eur. J. Prev. Cardiol. 25, 1502–1519 (2018). (PMID: 10.1177/2047487318776829)
Alshiek, J. A. et al. Anti-oxidative treatment with vitamin E improves peripheral vascular function in patients with diabetes mellitus and haptoglobin 2-2 genotype. Diab. Res. Clin. Pr. 131, 200–207 (2017). (PMID: 10.1016/j.diabres.2017.06.026)
Saha, N. & Ong, Y. W. Distribution of haptoglobins in different dialect groups of Chinese, Malays and Indians in Singapore. Ann. Acad. Med. Singap. 13, 498–501 (1984). (PMID: 6517517)
Levey, A. S. et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150, 604–612 (2009). (PMID: 10.7326/0003-4819-150-9-200905050-00006)
Soejima, M. & Koda, Y. TaqMan-based real-time PCR for genotyping common polymorphisms of haptoglobin (HP1 and HP2). Clin. Chem. 54, 1908–1913 (2008). (PMID: 10.1373/clinchem.2008.113126)
Rubinshtein, R. et al. Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur. Heart J. 31, 1142–1148 (2010). (PMID: 10.1093/eurheartj/ehq010)
Bonpei, T. & Yuko, H. Disparity between EndoPat measurement and brachial artery flow-mediated vasodilatation in hypertensive patients. JACC 61(10 Supplement), E2100 (2013).
Vassalle, C. An easy and reliable automated method to estimate oxidative stress in the clinical setting. Methods Mol. Biol. 477, 31–39 (2008). (PMID: 10.1007/978-1-60327-517-0_3)
Holvoet, P., Stassen, J. M., Van Cleemput, J., Collen, D. & Vanhaecke, J. Oxidized low density lipoproteins in patients with transplant‐associated coronary artery disease. Arterioscler Thromb. Vasc. Biol. 18, 100–107 (1998). (PMID: 10.1161/01.ATV.18.1.100)
Criockshank, K. et al. Aortic pulse wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 106, 2085–2090 (2002). (PMID: 10.1161/01.CIR.0000033824.02722.F7)
Touboul, P. J., Hennerici, M. G. & Meairs, S. Mannheim Carotid intima-media thickness consensus (2004–2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc. Dis. 23, 75–80 (2007). (PMID: 10.1159/000097034)
Aversa, A. et al. Chronic administration of sildenafil improves markers of endothelial function in men with type 2 diabetes. Diabet. Med. 25, 37–44 (2008). (PMID: 10.1111/j.1464-5491.2007.02298.x)
Economides, P. A. et al. The effect of vitamin E on endothelial function of micro- and macrocirculation and left ventricular function in type 1 and type 2 diabetic patients. Diabetes 54, 204–211 (2005). (PMID: 10.2337/diabetes.54.1.204)
Steinberg, D. Clinical trials of antioxidants in atherosclerosis: are we doing the right thing? Lancet 346, 36–38 (1995). (PMID: 10.1016/S0140-6736(95)92657-7)
Huang, J. et al. Relationship between serum alpha-tocopherol and overall and cause-specific mortality. Circ. Res. 125, 29–40 (2019). (PMID: 10.1161/CIRCRESAHA.119.314944)
Costacou, T., Levy, A. P. & Miller, R. G. Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial. Acta Diabetol. 53, 243–250 (2016). (PMID: 10.1007/s00592-015-0770-8)
Bowry, V. W. & Stocker, R. Tocopherol-mediated peroxidation. The prooxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J. Am. Chem. Soc. 115, 6029–6044 (1993). (PMID: 10.1021/ja00067a019)
Miyazawa, T., Burdeos, G. C., Itaya, M. & Nakagawa, K. Vitamin E: regulatory redox interactions. IUBMB Life 71, 430–441 (2019). (PMID: 10.1002/iub.2008)
Miller, E. R. et al. Meta-analysis: high dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med 142, 37–46 (2005). (PMID: 10.7326/0003-4819-142-1-200501040-00110)
Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G. & Gluud, L. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst. Rev. 14, CD007176 (2012).
Jiang, Q. Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy. Free Radic. Biol. Med. 72, 76–90 (2014). (PMID: 10.1016/j.freeradbiomed.2014.03.035)
Costacou, T. et al. Is magnetic resonance imaging detection of kidney iron deposition increased in haptoglobin 2-2 genotype carriers with type 1 diabetes? Antioxid. Redox Signal 29, 735–741 (2018). (PMID: 10.1089/ars.2017.7444)
Dalan, R., Liu, X., Goh, L. L., Bing, S. & Luo, K. Q. Endothelial cell apoptosis correlates with low haptoglobin concentrations in diabetes. Diab. Vasc. Dis. Res. 14, 534–539 (2017). (PMID: 10.1177/1479164117719827)
Langlois, M. R. & Delanghe, J. R. Biological and clinical significance of haptoglobin polymorphism in humans. Clin. Chem. 42, 1589–1600 (1996). (PMID: 10.1093/clinchem/42.10.1589)
Schnabel, R. B. et al. Noninvasive vascular measurement in the community: cross-sectional relations and comparison of methods. Circ. Cardiovasc Imaging 4, 371–380 (2011). (PMID: 10.1161/CIRCIMAGING.110.961557)